Platform Technology Partners Abb Vie Inc. Transaction History

Platform Technology Partners

$385 Million
Q3 2025

A detailed history of Platform Technology Partners transactions in Abb Vie Inc. stock. As of the latest transaction made, Platform Technology Partners holds 10,026 shares of ABBV stock, worth $2.19 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares

10,026

Previous 10,267 2.35%

Holding current value

$2.19 Million

Previous $1.91 Million 21.84%

% of portfolio

0.6%

Previous 0.54%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 29, 2025	SELL	$184.85 - $231.54 $44,548 - $55,801	-241 Reduced 2.35%	10,026 $2.32 Million
Q2 2025 Aug 11, 2025	BUY	$170.16 - $206.27 $35,393 - $42,904	208 Added 2.07%	10,267 $1.91 Million
Q1 2025 May 01, 2025	BUY	$169.2 - $216.66 $144,496 - $185,027	854 Added 9.28%	10,059 $2.11 Million
Q4 2024 Jan 28, 2025	SELL	$164.99 - $203.87 $159,050 - $196,530	-964 Reduced 9.48%	9,205 $1.64 Million
Q3 2024 Nov 04, 2024	SELL	$163.84 - $199.33 $45,875 - $55,812	-280 Reduced 2.68%	10,169 $2.01 Million
Q2 2024 Jul 30, 2024	BUY	$154.79 - $180.76 $132,500 - $154,730	856 Added 8.92%	10,449 $1.79 Million
Q4 2023 Feb 13, 2024	SELL	$137.6 - $154.97 $32,060 - $36,108	-233 Reduced 2.37%	9,593 $1.49 Million
Q3 2023 Nov 08, 2023	BUY	$133.59 - $154.65 $131,986 - $152,794	988 Added 11.18%	9,826 $1.46 Million
Q2 2023 Jul 12, 2023	SELL	$132.51 - $164.9 $12,985 - $16,160	-98 Reduced 1.1%	8,838 $1.19 Million
Q1 2023 Apr 04, 2023	SELL	$144.61 - $166.54 $108,312 - $124,738	-749 Reduced 7.73%	8,936 $1.42 Million
Q4 2022 Jan 11, 2023	SELL	$138.31 - $165.87 $16,735 - $20,070	-121 Reduced 1.23%	9,685 $0
Q3 2022 Oct 24, 2022	BUY	$134.21 - $153.93 $59,186 - $67,883	441 Added 4.71%	9,806 $1.32 Million
Q2 2022 Aug 04, 2022	SELL	$137.62 - $174.96 $127,711 - $162,362	-928 Reduced 9.02%	9,365 $1.43 Million
Q1 2022 May 03, 2022	BUY	$131.98 - $163.75 $30,883 - $38,317	234 Added 2.33%	10,293 $1.67 Million
Q4 2021 Feb 01, 2022	BUY	$107.43 - $135.93 $34,699 - $43,905	323 Added 3.32%	10,059 $1.36 Million
Q3 2021 Nov 04, 2021	SELL	$106.4 - $120.78 $296,749 - $336,855	-2,789 Reduced 22.27%	9,736 $1.05 Million
Q2 2021 Aug 05, 2021	BUY	$105.21 - $117.21 $11,257 - $12,541	107 Added 0.86%	12,525 $1.41 Million
Q4 2020 Feb 09, 2021	BUY	$80.49 - $108.67 $73,487 - $99,215	913 Added 7.94%	12,418 $1.33 Million
Q3 2020 Nov 30, 2020	BUY	$85.91 - $100.83 $687 - $806	8 Added 0.07%	11,505 $1.01 Million
Q2 2020 Nov 30, 2020	BUY	$73.37 - $98.18 $139,403 - $186,542	1,900 Added 19.8%	11,497 $1.13 Million
Q1 2020 Nov 30, 2020	BUY	$64.5 - $97.79 $183,825 - $278,701	2,850 Added 42.24%	9,597 $731,000
Q4 2019 Dec 03, 2020	BUY	$72.13 - $90.25 $486,661 - $608,916	6,747 New	6,747 $597,000

Others Institutions Holding ABBV

# of Institutions

4,375

Shares Held

1.3B

Call Options Held

16.1M

Put Options Held

10.9M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $386B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Platform Technology Partners, based on Form 13F filings with the SEC.

News

Stay updated on Platform Technology Partners with notifications on news.

Account

Platform Technology Partners Abb Vie Inc. Transaction History